6171 C-terminal helical domain in Jumonji domain-containing histone demethylases
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous non-metal compounds | 2 | 1.5 | 1.35× | not tested | |
| Homogeneous metal compounds | 4 | 3.4 | 1.18× | not tested | |
| Organoheterocyclic compounds | 1 | 1.1 | 0.94× | not tested | |
| Organic acids and derivatives | 1 | 1.1 | 0.94× | not tested | |
| Organic oxygen compounds | 1 | 1.4 | 0.73× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB09140 | OXY | Oxygen | 3 |
| DB00126 | — | Ascorbic acid | 1 |
| DB03709 | BCN | Bicine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 5 |
| MGmetal | MAGNESIUM ION | 2 |
| BCN | BICINE | 1 |
| BGC | beta-D-glucopyranose | 1 |
| E67 | 7-[(5-aminopentyl)oxy]-N~4~-(1-benzylpiperidin-4-yl)-N~2~-[3-(dimethylamino)propyl]-6-methoxyquinazoline-2,4-diamine | 1 |
| PG0 | 2-(2-METHOXYETHOXY)ETHANOL | 1 |